Integer Holdings Corporation $ITGR Stock Sold by Cooke & Bieler LP

Cooke & Bieler LP lessened its stake in shares of Integer Holdings Corporation (NYSE:ITGR) by 22.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 274,743 shares of the medical equipment provider’s stock after selling 78,722 shares during the quarter. Cooke & Bieler LP’s holdings in Integer were worth $34,714,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Counterpoint Mutual Funds LLC acquired a new position in shares of Integer in the 3rd quarter valued at $894,000. Fortitude Family Office LLC grew its position in shares of Integer by 987.2% in the 3rd quarter. Fortitude Family Office LLC now owns 424 shares of the medical equipment provider’s stock valued at $54,000 after buying an additional 385 shares during the last quarter. GAMMA Investing LLC grew its position in shares of Integer by 12.7% in the 3rd quarter. GAMMA Investing LLC now owns 4,335 shares of the medical equipment provider’s stock valued at $548,000 after buying an additional 489 shares during the last quarter. Farther Finance Advisors LLC raised its stake in Integer by 64.4% during the 3rd quarter. Farther Finance Advisors LLC now owns 490 shares of the medical equipment provider’s stock worth $62,000 after acquiring an additional 192 shares in the last quarter. Finally, Canandaigua National Bank & Trust Co. acquired a new stake in Integer during the 3rd quarter worth $253,000. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Insider Buying and Selling at Integer

In related news, insider Andrew Senn sold 9,408 shares of the stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $126.30, for a total transaction of $1,188,230.40. Following the completion of the sale, the insider owned 5,405 shares in the company, valued at $682,651.50. This represents a 63.51% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Kirk K. Thor sold 11,767 shares of the firm’s stock in a transaction on Tuesday, September 15th. The stock was sold at an average price of $126.23, for a total transaction of $1,485,348.41. Following the transaction, the insider directly owned 7,153 shares in the company, valued at $902,923.19. The trade was a 62.19% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 40,948 shares of company stock valued at $5,169,920. 1.10% of the stock is owned by insiders.

Integer Price Performance

Shares of NYSE ITGR opened at $126.73 on Thursday. The company has a current ratio of 3.73, a quick ratio of 2.41 and a debt-to-equity ratio of 0.75. Integer Holdings Corporation has a twelve month low of $62.00 and a twelve month high of $126.83. The stock has a 50 day moving average of $126.06 and a two-hundred day moving average of $105.41. The stock has a market cap of $4.31 billion, a P/E ratio of 34.63, a P/E/G ratio of 2.41 and a beta of 0.58.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.38 by $0.22. The business had revenue of $464.11 million during the quarter, compared to the consensus estimate of $451.07 million. Integer had a return on equity of 12.79% and a net margin of 6.97%. The company’s revenue was down 2.6% compared to the same quarter last year. During the same period in the prior year, the company earned $1.55 earnings per share. On average, research analysts forecast that Integer Holdings Corporation will post 6.09 earnings per share for the current year.

Wall Street Analyst Weigh In

ITGR has been the subject of a number of research reports. Benchmark cut shares of Integer from a “buy” rating to a “hold” rating in a research report on Thursday, August 13th. Zacks Research upgraded shares of Integer from a “strong sell” rating to a “hold” rating in a research note on Monday, July 20th. Raymond James Financial lowered Integer from a “moderate buy” rating to a “hold” rating in a report on Monday, August 3rd. Freedom Capital cut Integer from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 4th. Finally, Truist Financial cut Integer from a “buy” rating to a “hold” rating and lifted their target price for the stock from $110.00 to $127.00 in a research report on Monday, August 3rd. One investment analyst has rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $109.86.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global medical device and advanced energy technology company. It partners with original equipment manufacturers to design and manufacture components, subassemblies and finished products used in minimally invasive and implantable medical devices.

Its medical technologies include batteries and power systems for pacemakers, implantable cardioverter-defibrillators, neurostimulators and drug-delivery systems, as well as catheter and guidewire components, coated wire, electrodes and other products used in cardiovascular, neuromodulation and other medical applications.

Integer also develops specialty batteries and power solutions for markets such as energy, aerospace and defense.